Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China
BackgroundThe National Drug Price Negotiation (NDPN) policy is a key institutional reform in China that reshaped drug market access rules. While its effects on drug prices and accessibility are well documented, evidence on firm-level innovation performance remains limited. This study evaluates the i...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-11-01
|
| Colección: | Frontiers in Public Health |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1705030/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|